CEO and Founder Naomi Pearce has been recommended in the Lexology Index – Healthcare & Life Sciences 2026, with recognition in the highly competitive Patent Litigation category.
In November 2025 Naomi was also recognised by Lexology as the 2026 Client Choice Award Recipient for IP Patents (Australia).
The Lexology Index – Healthcare & Life Sciences identifies leading practitioners across 54 countries, recognising lawyers who have demonstrated exceptional expertise, industry knowledge and client service within the healthcare and life sciences sectors, providing a comprehensive guide to the lawyers shaping the industry’s most significant matters worldwide.
Naomi is one of just 12 Australian lawyers recognised for Patent Litigation, highlighting her reputation as a trusted adviser to pharmaceutical companies navigating complex intellectual property challenges.
Lexology researchers received outstanding feedback from market sources on Naomi’s work, including:
“She is hugely knowledgeable on IP issues surrounding commercial aspects of preparing product launch and assessing risks involved.”
Pearce IP Deputy CEO, Peter O’Sullivan, said the recognition reflects Naomi’s standing as one of Australia’s leading intellectual property litigators.
“Naomi has built a reputation for providing commercially focussed, strategic advice that helps clients confidently navigate complex patent disputes and regulatory challenges. This recognition is a testament to her expertise, leadership and unwavering commitment to achieving exceptional outcomes for clients across the life sciences and healthcare sectors.”
Naomi Pearce said she was honoured to be recognised.
“Healthcare & life sciences are exciting industries to support, as they push the boundaries of what is possible to improve our quality of life. I feel very privileged to be recognised by Lexology as one of 12 leading patent litigators in Australia, but the honour belongs to the entire Pearce IP litigation team, who are without peer.”
This recognition further strengthens Pearce IP’s position as a leading intellectual property practice in Australia and New Zealand, supporting businesses with strategic advice across patents, trade marks, commercialisation, disputes and enforcement.
About Pearce IP
Pearce IP is a privately owned/independent, specialist, life-sciences focussed, intellectual property/law firm offering lawyers and attorneys in Australia and New Zealand.
Our lawyers and attorneys specialise in pharma, biopharma, biotech, ag-tech, food-tech, med-tech, although our work is broader than these industries.
Pearce IP and its leaders are ranked in every notable legal directory including: Chambers & Partners, Legal 500, IAM Patent 1000, IAM Strategy 300, MIP IP Stars, Doyles Guide, WTR 1000, Best Lawyers, WIPR Leaders, Best Law Firms, among others. In 2025, Pearce IP was honoured by Australasian Lawyer and New Zealand Lawyer as a Top Specialist Firm, 5 Star Employer of Choice, and the “Standout Winner” for Inclusion and Culture (<100 employees).
Pearce IP is the only leading IP firm in Australia and New Zealand with a female founder, and is certified by WEConnect International as women owned.
Naomi Pearce
CEO, Executive Lawyer (AU, NZ), Patent & Trade Mark Attorney (Trans Tasman)
Naomi is the CEO and Founder of Pearce IP, and is one of ANZ’s leading IP practitioners. Naomi is a market leading, strategic, commercially astute, patent lawyer, patent attorney and trade mark attorney, with over 29 years’ experience, and a background in molecular biology/biochemistry.
Ranked in virtually every notable legal directory, highly regarded by peers and clients, Naomi is renowned for her successful and elegant IP/legal strategies focussing on complex/multijurisdictional litigation, global FTO, and strategic advice. Among other awards, Naomi is the 2026 Lexology Client Choice Winner for Patents, the 2024 Lawyers Weekly Women in Law “Executive of the Year”, the 2023 Lawyers Weekly “IP Partner of the Year”, the 2022 Lexology Client Choice Winner for Life Sciences, the 2022 Asia Pacific Women in Business Law “Patent Lawyer of the Year”, and the 2021 Lawyers Weekly Women in Law “Partner of the Year”. Ranked in Chambers Asia Pacific, Chambers Global, IAM Patent 1000, IAM Strategy 300, is a MIP “Patent Star”, and is recognised as a WIPR Leader for patents and trade marks.
Pearce IP is the premier life sciences focussed firm in ANZ. Commencing in 2017. Pearce IP is the 2025 Australasian Lawyer and NZ Lawyer 5-Star Employer of Choice & “Standout Winner” for Inclusion and Culture (<100 employees). In 2021, Pearce IP was the Lawyers Weekly Australian Law Awards IP Team of the Year.